Literature DB >> 1537169

Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo.

H Nakahara1, V M Goldberg, A I Caplan.   

Abstract

Chick tibial periosteal cells were enzymatically disaggregated, introduced into cell culture, and subcultured. These subcultured cells were combined with porous calcium phosphate ceramics and implanted into a subcutaneous site in athymic mice as an immunocompatible host to test the in vivo osteochondrogenic potential of this composite graft. These cells eventually gave rise to bone tissue in the pores of ceramics at the heterotopic implantation sites. The process of bone formation occurred through two different mechanisms: Intramembranous bone formation occurred at the peripheral pores of ceramics early, and endochondral bone formation occurred in the central pores later. Cultured chick muscle fibroblasts of the same-aged donor as controls did not form bone or cartilage under identical conditions to those of cultured periosteal-derived cells. These results raise the possibility that composite graft of cultured periosteal-derived cells and porous ceramics can be clinically used as a bone graft substitute in situations requiring bone augmentation or regeneration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537169

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

1.  Engineering growing tissues.

Authors:  Eben Alsberg; Kenneth W Anderson; Amru Albeiruti; Jon A Rowley; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

2.  Interactions of human osteoprogenitors with porous ceramic following diffusion chamber implantation in a xenogeneic host.

Authors:  R Gundle; C J Joyner; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1997-08       Impact factor: 3.896

3.  Osteogenic Potential of Mouse Periosteum-Derived Cells Sorted for CD90 In Vitro and In Vivo.

Authors:  You-Kyoung Kim; Hidemi Nakata; Maiko Yamamoto; Munemitsu Miyasaka; Shohei Kasugai; Shinji Kuroda
Journal:  Stem Cells Transl Med       Date:  2015-12-30       Impact factor: 6.940

Review 4.  Orthobiologics in the augmentation of osteoporotic fractures.

Authors:  J Tracy Watson; Daemeon A Nicolaou
Journal:  Curr Osteoporos Rep       Date:  2015-02       Impact factor: 5.096

5.  Tissue-engineered composite scaffold of poly(lactide-co-glycolide) and hydroxyapatite nanoparticles seeded with autologous mesenchymal stem cells for bone regeneration.

Authors:  Bing Zhang; Pei-Biao Zhang; Zong-Liang Wang; Zhong-Wen Lyu; Han Wu
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

6.  Biocompatibility studies of human fetal osteoblast cells cultured on gamma titanium aluminide.

Authors:  Omayra Rivera-Denizard; Nannette Diffoot-Carlo; Vivian Navas; Paul A Sundaram
Journal:  J Mater Sci Mater Med       Date:  2007-06-28       Impact factor: 3.896

7.  The Habitat Assay, a Platform to Study In Vivo Properties of Human Mesenchymal Stem Cells.

Authors:  Donald P Lennon; Rodrigo A Somoza; Mark A Schluchter; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2020-11-26       Impact factor: 3.845

8.  The benefit of a human bone marrow stem cells concentrate in addition to an inorganic scaffold for bone regeneration: an in vitro study.

Authors:  J Torres; A Lopes; M A Lopes; M Gutierres; A T Cabral; M H Fernandes; E Monteiro; C F van Eck; J D Santos
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

Review 9.  The role of orthobiologics in foot and ankle surgery: Allogenic bone grafts and bone graft substitutes.

Authors:  James Wee; Gowreeson Thevendran
Journal:  EFORT Open Rev       Date:  2017-06-01

10.  A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling.

Authors:  J Eyckmans; S J Roberts; J Schrooten; F P Luyten
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.